THE ROLE OF D-DIMER AT SCREENING VENOUS THROMBOSIS IN ADVANCED CANCER PATIENTS Panagiotis Heras (1), Theodosis Andrianopoulos (1), Ioannis Tsiverdis (1),

Slides:

Advertisements

Similar presentations

Diagnosing venous thromboembolism – protocols and problems, the Salford experience Kerstin Hogg Clinical Lecturer, University of Manchester.

Advertisements

Preventing Hospital Associated Thrombosis: measuring outcomes Roopen Arya King’s College Hospital VTE Prevention NHS Showcase 16 September 2013.

VTE Toolkit Chapter Five Venous Disease Coalition

Risk stratification and incidence of acute complications in upper extremity deep vein thrombosis (UEDVT) patients. Dr. Santosh Yatam Ganesh MBBS, MPH.,

Working together to achieve nursing excellence in VTE Katrina Glaister Clinical Governance Facilitator (VTE Project Nurse) Salisbury NHS Foundation Trust.

Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.

Venous Thromboembolism

RHQN Best Practice Call: Partnership for Patients (PfP) focus: VTE Tuesday, April 10, 2012.

RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.

IMPACT OF PARACENTESIS ON HEALTH-RELATED QUALITY-OF-LIFE (HRQoL) IN WOMEN WITH OVARIAN CANCER (OC) AND MALIGNANT ASCITES (MA) Panagiotis Heras (1), Theodosis.

POSTERIOR SQUAMOUS-LIKE MULTIFOCAL PIGMENTED EPITHELIOPATHY (PSMPE) AS THE FIRST CLINICAL MANIFESTATION OF A 23 YEAR OLD FEMALE PATIENT WITH UNCLASSIFIED.

Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.

Integrated regional Palliative Care Services – supporting end of life care Options Dr Robin Fainsinger Professor & Director Division of Palliative Care.

Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose,

Quality of life in elderly long-term cancer survivors P. Heras, T. Andrianopoulos, I. Tsiverdis, I. Georgopoulos, A. Hatzopoulos Clinic of Internal Medicine,

HIT Policy Committee Patient Safety Tiger Team Summary Neil Calman Institute for Family Health October 28, 2010.

DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?

A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.

به نام خدا. دكتر محمد امامي فوق تخصص ريه عضو هيات علمي دانشگاه.

Service d’Hématologie Biologique Hôpital Tenon, APHP, Paris, France Group Thrombosis and Cancer Cancer Biology and Therapeutics Centre de Recherche Saint-Antoine.

Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,

Low-molecular-weight heparin (LMWH) use in an oncological setting Emma Lowe, Melanie Lowe, Hilary Oldham, Joan Karasu. Clinical service technicians, Pharmacy.

Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.

Therapeutic Significance of D-dimer Cut-off Level of more than 3 µg/ml in Colorectal Cancer Patients Treated with Standard Chemotherapy plus Bevacizumab.

Objectives Methods ‘ Whooley’ questions were provided to all clinical staff from July Retrospectively, a random sample of patients who presented.

ST CATHERINE’S HOSPICE Primary thromboprophylaxis in advanced disease MJ Johnson.

Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.

MORTALITY AUDIT Dr S Callin SpR Palliative Medicine Dr L Russon Consultant Palliative Medicine BRI Palliative Care Team.

DVT Prevention and Anticoagulant Management

VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.

A Primary Care Trust Perspective NHS North Lancashire.

Chapter Seven Venous Disease Coalition Long-Term Management of VTE VTE Toolkit.

DIAGNOSIS OF PRIMARY THYROID LYMPHOMA THROUGH FINE-NEEDLE ASPIRATION BIOPSY (FNAB) Panagiotis Heras (1), Theodosis Andrianopoulos (1), Ioannis Tsiverdis.

Venous thromboembolism in the palliative care setting: what are the challenges? Dr Simon Noble Cardiff University and Royal Gwent Hospital.

Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,

Jane Balmer & Kirsty McNeil University of Dundee College of Medicine, Nursing & Dentistry Recognising Delirium in an Acute Medical Setting Results Introduction.

Risk assessment for VTE Dr Roopen Arya King’s College Hospital.

Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.

Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.

SUBCUTANEOUS METASTASES OF MALIGNANT NEOPLASMS Panagiotis Heras (1), Theodosis Andrianopoulos (1), Nikolaos Roussakis (1), Ioannis Tsiverdis (1), Ilias.

 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.

Prof. Mona Mansour Professor of Pulmonary Medicine Ain Shams University.

OSTEOMALACIA DUE TO MESENCHYMAL TUMOR: SCINTIGRAPHIC DETECTION WITH OCTREOTIDE In-111 Panagiotis Heras (1), Theodosis Andrianopoulos (1), Ioannis Tsiverdis.

Introducing TROPHY Simon Noble Cardiff University.

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study by Cheng E. Chee, Aneel A. Ashrani,

Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital

Checklist overlap: Prevention of Surgical Site Infection and Venous Thromboembolism Marlies van Dijk, Western Node Leader Safer Healthcare Now! Safe Surgery.

Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-LegColor-CodedDopplerUltrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis A Randomized.

Pulmonary Embolism in Patients with Unexplained Exacerbation of COPD: Prevalence and Risk Factors Isabelle Tillie-Leblond, MD, PhD; Charles-Hugo Marquette,

Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thrombosis Research (2008)

Anthony Williams, FY2 Jo McCarthy, FY2 Charlotte Davies, FY2

the proximal femoral fracture patients

Venous Thromboembolism Prophylaxis (VTE)

Diagnosis of venous thromboembolism

Deep vein thrombosis outpatient pathway and ultrasound sensitivity

Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon

Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome

NOACs for Cancer-Associated Thrombosis:

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis by Paolo Prandoni,

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

The Burden of Hospital-Associated Venous Thromboembolism

BMP Ordering Practice Among UCI Wards Teams

The emerging role of community sentinel surveillance in the understanding of the clinical features and epidemiology of acute Mycoplasma pneumoniae infection

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study by Ian Litchfield, David Fitzmaurice, Patricia Apenteng,

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.

Presentation transcript:

THE ROLE OF D-DIMER AT SCREENING VENOUS THROMBOSIS IN ADVANCED CANCER PATIENTS Panagiotis Heras (1), Theodosis Andrianopoulos (1), Ioannis Tsiverdis (1), Ilias Georgopoulos (1), Antonios Hatzopoulos (1) (1) Clinic of Internal Medicine, General Hospital of Nafplio, GREECE

Introduction: The incidence of venous thromboembolism (VTE) in advanced cancer patients is up to %. D-Dimer is used as screening test for VTE due to its high sensitivity and low cost. But, it is frequently elevated by other causes, like infection or malignancy. Objectives: To assess D-Dimer utility as screening test for VTE in advanced cancer patients. Methods: Patients with incurable cancer and swollen leg or other factors (according to Well’s clinical DVT model) underwent D-Dimer test at admission according to our team’s policy. This report is retrospective analysis of patients who were admitted in palliative care ward from July 2010 to December 2014.

Results: Among 125 incurable cancer patients, 103 had Well’s score ≥2 at admission. Among 103 patients, only 5 had normal D-Dimer ( 2.0 μg/mL. Conclusions: In advanced cancer patients, D-Dimer may lack its screening value for VTE. Patients without VTE also have high level of D- Dimer. A novel cost-effective tool is necessary for screening VTE.